Release Summary

X4 Pharmaceuticals presented preclinical data for X4P-001, the Company’s lead drug candidate, at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, held 11/29-12/2 in Munich.

X4 Pharmaceuticals